[O25-6-3] UHPLC-MS/MS based quantification of DOACs and application to patients undergoing cardiac catheterization treated with rivaroxaban
Keywords:DOACs, rivaroxaban, interventional procedures, LC-MS/MS, anti-FXa activity
Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.